Over 400 Total Lots Up For Auction at Two Locations - NJ 05/08, WA 05/09

640-slice CT scanner reduces radiation exposure, study

by Loren Bonner, DOTmed News Online Editor | February 01, 2013
Toshiba's Aquilion One Vision Edition
A new study in the journal Radiology looks to new technology to narrow some of the concern around coronary CT angiography (CCTA), a procedure known to be clinically effective, but is sometimes controversial for fear of exposing patients to cancer risk down the road because of high radiation dose.

For the study, 107 patients underwent heart scans during CCTA procedures using Toshiba's Aquilion One Vision Edition, which has the advantage of a gantry rotation time of 275 milliseconds, automated exposure control, a larger X-ray power generator and 320 detector rows — giving it the title of 640-slice scanner. Analysis of the patients from National Institutes of Health researchers found that radiation exposure was reduced by as much as 95 percent compared to the current offering of CT scanners, which are normally 64-row detector scanners.

The study also found that resulting images looked clearer and captured more detail. In addition to hardware advances, the research team incorporated third-generation iterative dose reconstruction software, which can optimize radiation usage and image quality.
stats
DOTmed text ad

New Fully Configured 80-slice CT in 2 weeks with Software Upgrades for Life

For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.

stats
"These multiple advancements work together to allow us to image the entire heart within one heartbeat about 93 percent of the time," said lead study author Dr. Marcus Chen, in a statement from NIH.

More studies will need to be conducted before the system can be adopted for wider clinical use, said the statement.

Aquilion One Vision Edition was cleared by the U.S. Food and Drug Administration in September 2012 with only one U.S. install at the NIH. It's in use worldwide at Fujita Health University in Japan; Radboud University Nijmegen Medical Centre in the Netherlands; Monash Medical Centre Clayton, Southern Health in Australia; Hong Kong Sanatorium & Hospital in Hong Kong; and Iwate Medical University in Japan. Future installations include University Health Network-Toronto General Hospital in Canada and Rigshospitalet in Denmark.

You Must Be Logged In To Post A Comment